UCSF and Northwestern Awarded $4.2M to Advance Glioblastoma Therapeutics
Glioblastoma is the most common malignant brain tumor and among the most treatment-resistant cancers. In the last 15 years, numerous attempts to develop new drugs for glioblastoma have failed.